Home Products Drug Discovery>> Inhibitor Cardiovascular and blood system EGFR AZD3759
AZD3759 - CAS 1626387-80-1
Catalog number: B0084-470884
Ordering Information
Clinical Trial Information
NCT Number
Title
Condition Or Disease
Phase
Start Date
Sponsor
Status
NCT02228369 Oral Epidermal Growth Factor
Receptor Tyrosine Kinase
Inhibitors, AZD3759 or AZD9291,
in Patients Who Have Advanced
Non-Small Cell Lung Cancer
EGFR Mutation
Positive Advanced
Non Small Cell Lung
Cancer
Phase 1
November
5, 2014
AstraZeneca
Active,
not
recruiting
NCT03360929 Evaluate Safety, Tolerability,
Non Small Cell Lung
Phase 2
October
LYZZ Alpha
Recruiting
AZD3759 is a n orally available inhibitor of the epidermal growth factor receptor (EGFR),
with potential antineoplastic activity. Upon oral administration, AZD3759 binds to and
inhibits the activity of EGFR as well as certain mutant forms of EGFR.
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category
Inhibitor
Targets
EGFR
Molecular Formula
C22H23ClFN5O3
Molecular Weight
459.91
Catalog Number
Size
Price
Stock
Quantity
B0084-470884
1 g
$179
In stock
0
Bulk Inquiry
Add to cart
Chemical Information
Category
Inhibitor
Molecular Formula
C22H23ClFN5O3
Molecular Weight
459.91
Purity
98%
Appearance
Solid powder
Synonyms
AZD3759; AZD-3759; AZD 3759.
Solubility
Soluble in DMSO, not in water
Storage
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Shelf Life
2 years if stored properly
Specification
Properties
Reference
Reading
Quick Inquiry
Featured Items
Name
Name
Email *
Email
Phone *
Phone
Quantity *
Quantity
Services & Products of Interest *
[Inhibitor] (B0084-470884)
AZD3759
Project Description
Project Description
Verification Code
*
Verification code
SUBMIT
Drug Discovery
ADCs
APIs & Intermediates
Impurities
Inhibitors
Metabolites
Pharmaceutical Excipients
Chemistry
Building Blocks
Chiral Compounds
Disinfectants
Flavor & Fragrance
Labelled Products
Natural Compounds
Please input